^
Association details:
| Biomarker: | TP53 wild-type |
|---|---|
| Cancer: | Small Lymphocytic Lymphoma |
| Regimen: | (cyclophosphamide + pentostatin + Rituxan (rituximab)) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:…CLL/SLL without del(17p)/TP53 mutation...Other recommended regimens…PCR (pentostatin, cyclophosphamide, rituximab) (category 3)
